Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. Biotech drug discovery...
— Harvey Sax
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on iShares Biotechnology ETF
No other institutional pitches found for this ticker yet.
More institutional theses from Alpha Wealth Funds - The Insiders Fund
GE HealthCare Technologies ($GEHC) represents 2.4% of the fund's portfolio. The enterprise is...
Grab Holdings ($GRAB) is a new portfolio position accounting for 1.8% of assets. The company operates...
Boston Scientific ($BSX) represents 5.7% of the fund's portfolio. The company designs,...